AMPE Related Press Releases
Ampio Pharmaceuticals Announces Participation at the UBS Global Healthcare Conference
Ampio Pharmaceuticals Completes Enrollment in Run-In SPRING study of Ampion in Osteoarthritis of the Knee
Ampio Receives FDA Clearance to Initiate Clinical Trial of Ampion™ for the Treatment of Osteoarthritis of the Knee: Patient Treatments have begun.
Back to AMPE Stock Lookup